Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

URSODIOL for Cholangitis sclerosing: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 82 adverse event reports in the FDA FAERS database where URSODIOL was used for Cholangitis sclerosing.

Most Reported Side Effects for URSODIOL

Side Effect Reports % Deaths Hosp.
Off label use 444 12.3% 75 136
Drug ineffective 383 10.6% 89 142
Foetal exposure during pregnancy 262 7.2% 19 59
Maternal exposure during pregnancy 210 5.8% 2 63
Pruritus 197 5.4% 8 47
Premature baby 176 4.9% 12 58
Exposure during pregnancy 162 4.5% 2 72
Nausea 149 4.1% 13 67
Product use in unapproved indication 135 3.7% 38 33
Death 124 3.4% 124 19
Diarrhoea 115 3.2% 9 38
Condition aggravated 97 2.7% 14 60
Pneumonia 96 2.7% 15 44
Drug ineffective for unapproved indication 92 2.5% 12 32
Pyrexia 91 2.5% 14 69

Other Indications for URSODIOL

Product used for unknown indication (1,357) Primary biliary cholangitis (203) Prophylaxis (199) Cholestasis of pregnancy (172) Cholestasis (150) Cholelithiasis (99) Cholangitis (69) Pruritus (64) Foetal exposure during pregnancy (61) Liver disorder (58)

Other Drugs Used for Cholangitis sclerosing

MYCOPHENOLATE MOFETIL (52) PREDNISOLONE (41) AZATHIOPRINE (40) PREDNISONE (38) INFLIXIMAB (31) TACROLIMUS (29) ADALIMUMAB (23) METHYLPREDNISOLONE (23) MESALAMINE (20) RITUXIMAB (19)

Related Pages

URSODIOL Full Profile All Cholangitis sclerosing Drugs URSODIOL Demographics URSODIOL Timeline